Assessing pain catastrophizing and functional disability in pediatric epidermolysis bullosa patients.
Autor: | Rangu S; Section of Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Collins J; Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., García-Romero MT; Dermatology Department, Instituto Nacional de Pediatría, Mexico City, Mexico., Augsburger BD; Department of Dermatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Bruckner AL; Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA., Diaz LZ; Division of Dermatology and Dermatologic Surgery, Department of Internal Medicine, Dell Medical School at the University of Texas at Austin, Austin, Texas, USA., Eichenfield LF; Department of Dermatology, University of California San Diego, San Diego, California, USA.; Department Pediatrics, University of California San Diego, San Diego, California, USA.; Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, California, USA., Faig W; Children's Hospital of Philadelphia, Research Institute, Philadelphia, Pennsylvania, USA., Gorell ES; Department of Dermatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Dermatology, Stanford University School of Medicine, Redwood City, California, USA., Lefferdink R; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Lucky AW; Department of Dermatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Morel KD; Department of Dermatology, Vagelos College of Physicians & Surgeons, Columbia University Medical Center, New York, New York, USA.; Department of Pediatrics, Vagelos College of Physicians & Surgeons, Columbia University Medical Center, New York, New York, USA., Paller AS; Children's Hospital of Philadelphia, Research Institute, Philadelphia, Pennsylvania, USA., Park H; Department Pediatrics, University of California San Diego, San Diego, California, USA., Pastrana-Arellano E; Dermatology Department, Instituto Nacional de Pediatría, Mexico City, Mexico., Peoples K; Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA., Wiss K; Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Perman MJ; Section of Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Castelo-Soccio L; Section of Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Pediatric dermatology [Pediatr Dermatol] 2023 May-Jun; Vol. 40 (3), pp. 422-427. Date of Electronic Publication: 2022 Dec 29. |
DOI: | 10.1111/pde.15220 |
Abstrakt: | Background/objectives: The primary objective was to assess pain catastrophizing and functional disability in pediatric patients with epidermolysis bullosa (EB) and their parents/guardians. Secondary objectives included examining relationships between pain catastrophizing, functional disability, and correlations with other factors (e.g., age, disease severity, and percent of body surface area (BSA) involved). Methods: Patients with EB ages 8-16 and their parents/guardians who were English or Spanish speaking completed a one-time online survey. Parent measures included: demographics questionnaire, Pain Catastrophizing Scale-Parent (PCS), and Parent Functional Disability Inventory (FDI). Child measures included: PCS child and child FDI. Higher scores on both scales indicate higher levels of catastrophizing and functional disability. Results: Of 31 children, the mean age was 11.47 years and the majority (70.97%) had dystrophic EB. Mean scores were: 35.84 = PCS parent; 34.58 = PCS child; 30.87 = parent FDI; 29.77 = child FDI. Total scores for PCS parent, parent FDI, and child FDI increased significantly with disease severity and percentage of involved BSA (p < .01 for all). Total scores for PCS child increased significantly with percent of EB skin involvement (p = .04) but not disease severity. Older children reported more functional disability than their parents and younger children (p = .02). Conclusions: Our results demonstrate significant positive correlations between negative thoughts related to pain and the experience of functional difficulties in patients with EB and their caregivers. Psychological, psychiatric, and/or behavioral interventions to help managing chronic pain may be effective for patients with EB. (© 2022 Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.) |
Databáze: | MEDLINE |
Externí odkaz: |